Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -283,800.00% | -390.56% | -439.30% | -10,458.43% | 100.17% |
| Total Depreciation and Amortization | 116.67% | 83.33% | 66.67% | -89.21% | -94.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 13,101.92% | -- |
| Change in Net Operating Assets | 228.79% | 84.38% | 147.30% | 73,200.00% | -181.99% |
| Cash from Operations | 36.39% | -881.34% | -865.12% | 1,268.57% | -457.01% |
| Capital Expenditure | 80.00% | -- | -- | -351.85% | -50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.00% | -- | -- | -351.85% | -50.00% |
| Total Debt Issued | -18.36% | 35.94% | 1,619.90% | -198.72% | 282.63% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | -18.36% | 422.58% | 1,900.00% | -301.96% | 235.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | -984.62% | 316.54% | -125.27% | 22.46% |